 Javier Valle
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 33 | 2023 | 480 | 7.230 |
Why?
| | Coronary Artery Disease | 21 | 2023 | 698 | 3.990 |
Why?
| | Coronary Angiography | 15 | 2023 | 317 | 2.390 |
Why?
| | Myocardial Infarction | 15 | 2022 | 1046 | 1.840 |
Why?
| | Registries | 16 | 2023 | 2035 | 1.820 |
Why?
| | Peripheral Arterial Disease | 7 | 2022 | 475 | 1.810 |
Why?
| | Angioplasty, Balloon | 5 | 2022 | 93 | 1.730 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2022 | 130 | 1.690 |
Why?
| | ST Elevation Myocardial Infarction | 3 | 2019 | 54 | 1.620 |
Why?
| | Cardiovascular Agents | 3 | 2023 | 159 | 1.550 |
Why?
| | Coronary Artery Bypass | 7 | 2023 | 234 | 1.440 |
Why?
| | Veterans Health | 8 | 2020 | 186 | 1.380 |
Why?
| | Vascular Calcification | 7 | 2022 | 108 | 1.370 |
Why?
| | Veterans | 10 | 2023 | 1476 | 1.370 |
Why?
| | Femoral Artery | 7 | 2022 | 179 | 1.340 |
Why?
| | United States Department of Veterans Affairs | 18 | 2021 | 678 | 1.210 |
Why?
| | Coronary Vessels | 4 | 2020 | 248 | 1.140 |
Why?
| | Ischemia | 4 | 2019 | 409 | 1.080 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2019 | 463 | 1.080 |
Why?
| | Time-to-Treatment | 2 | 2019 | 205 | 1.060 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 229 | 1.050 |
Why?
| | Treatment Outcome | 37 | 2023 | 10811 | 1.050 |
Why?
| | Myocardial Revascularization | 5 | 2019 | 73 | 1.040 |
Why?
| | Atherectomy | 7 | 2022 | 37 | 1.010 |
Why?
| | Endovascular Procedures | 4 | 2019 | 312 | 1.000 |
Why?
| | Surgical Procedures, Operative | 6 | 2018 | 259 | 1.000 |
Why?
| | Coronary Occlusion | 2 | 2023 | 19 | 0.940 |
Why?
| | Preoperative Care | 3 | 2018 | 362 | 0.930 |
Why?
| | Hospital Mortality | 8 | 2021 | 911 | 0.910 |
Why?
| | Lower Extremity | 3 | 2018 | 427 | 0.900 |
Why?
| | Atrial Flutter | 1 | 2024 | 35 | 0.860 |
Why?
| | Angioplasty, Balloon, Coronary | 3 | 2013 | 141 | 0.830 |
Why?
| | United States | 34 | 2021 | 14841 | 0.830 |
Why?
| | Risk Factors | 29 | 2023 | 10388 | 0.830 |
Why?
| | Catheterization, Peripheral | 3 | 2021 | 109 | 0.810 |
Why?
| | Hospitals, Veterans | 3 | 2020 | 252 | 0.810 |
Why?
| | Embolic Protection Devices | 2 | 2021 | 12 | 0.790 |
Why?
| | Factor Xa Inhibitors | 1 | 2024 | 172 | 0.780 |
Why?
| | Pyridones | 1 | 2024 | 168 | 0.780 |
Why?
| | Aged | 39 | 2022 | 23961 | 0.760 |
Why?
| | Hemorrhage | 6 | 2024 | 722 | 0.760 |
Why?
| | Non-ST Elevated Myocardial Infarction | 2 | 2019 | 22 | 0.740 |
Why?
| | Technology Transfer | 1 | 2021 | 9 | 0.730 |
Why?
| | Radial Artery | 3 | 2021 | 68 | 0.730 |
Why?
| | Aspirin | 3 | 2020 | 387 | 0.720 |
Why?
| | Time Factors | 23 | 2020 | 6828 | 0.710 |
Why?
| | Pyrazoles | 1 | 2024 | 423 | 0.680 |
Why?
| | Coated Materials, Biocompatible | 4 | 2022 | 62 | 0.660 |
Why?
| | Atrial Fibrillation | 1 | 2024 | 388 | 0.630 |
Why?
| | Heart Arrest | 3 | 2019 | 339 | 0.630 |
Why?
| | Humans | 74 | 2024 | 137585 | 0.620 |
Why?
| | Risk Assessment | 16 | 2022 | 3457 | 0.620 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2021 | 180 | 0.610 |
Why?
| | Saphenous Vein | 1 | 2019 | 35 | 0.610 |
Why?
| | Graft Occlusion, Vascular | 1 | 2019 | 40 | 0.610 |
Why?
| | Centralized Hospital Services | 1 | 2018 | 6 | 0.600 |
Why?
| | Middle Aged | 34 | 2021 | 33479 | 0.580 |
Why?
| | Male | 47 | 2024 | 67762 | 0.570 |
Why?
| | Transportation of Patients | 1 | 2018 | 55 | 0.570 |
Why?
| | Arm | 1 | 2018 | 104 | 0.560 |
Why?
| | Fibrinolytic Agents | 2 | 2018 | 270 | 0.560 |
Why?
| | Peripheral Vascular Diseases | 1 | 2018 | 103 | 0.550 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 1 | 0.550 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 2 | 0.550 |
Why?
| | Papillary Muscles | 1 | 2017 | 13 | 0.550 |
Why?
| | Endarterectomy, Carotid | 1 | 2017 | 49 | 0.540 |
Why?
| | Healthcare Disparities | 3 | 2018 | 654 | 0.540 |
Why?
| | Tibial Arteries | 1 | 2017 | 12 | 0.530 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 263 | 0.530 |
Why?
| | Atherectomy, Coronary | 3 | 2022 | 10 | 0.530 |
Why?
| | Renal Artery Obstruction | 1 | 2017 | 30 | 0.520 |
Why?
| | Renal Artery | 1 | 2017 | 37 | 0.520 |
Why?
| | Carotid Stenosis | 1 | 2017 | 91 | 0.510 |
Why?
| | Popliteal Artery | 3 | 2022 | 59 | 0.510 |
Why?
| | Disease Management | 2 | 2019 | 628 | 0.510 |
Why?
| | Decision Support Systems, Clinical | 1 | 2019 | 226 | 0.500 |
Why?
| | Female | 44 | 2024 | 73304 | 0.500 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 445 | 0.490 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2016 | 92 | 0.480 |
Why?
| | Ticlopidine | 1 | 2015 | 52 | 0.470 |
Why?
| | Exercise Test | 1 | 2018 | 625 | 0.460 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 201 | 0.460 |
Why?
| | Heart Diseases | 1 | 2018 | 346 | 0.460 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 530 | 0.450 |
Why?
| | Stents | 8 | 2020 | 527 | 0.440 |
Why?
| | Anticoagulants | 2 | 2016 | 664 | 0.440 |
Why?
| | Postoperative Complications | 6 | 2019 | 2654 | 0.440 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1313 | 0.440 |
Why?
| | Obesity | 2 | 2019 | 2992 | 0.430 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 323 | 0.430 |
Why?
| | Contrast Media | 1 | 2017 | 467 | 0.430 |
Why?
| | Heart Conduction System | 2 | 2013 | 99 | 0.410 |
Why?
| | Adrenergic Antagonists | 1 | 2013 | 7 | 0.410 |
Why?
| | Aged, 80 and over | 12 | 2024 | 7635 | 0.410 |
Why?
| | Mental Health | 1 | 2019 | 726 | 0.390 |
Why?
| | Stroke | 5 | 2022 | 1120 | 0.370 |
Why?
| | Odds Ratio | 7 | 2021 | 1070 | 0.370 |
Why?
| | Cohort Studies | 9 | 2021 | 5742 | 0.360 |
Why?
| | Health Services Accessibility | 1 | 2018 | 986 | 0.340 |
Why?
| | Thromboembolism | 2 | 2024 | 119 | 0.340 |
Why?
| | Patient Discharge | 2 | 2016 | 897 | 0.340 |
Why?
| | Aortic Valve | 4 | 2022 | 351 | 0.330 |
Why?
| | Mental Disorders | 1 | 2019 | 1077 | 0.330 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1040 | 0.330 |
Why?
| | Vascular Access Devices | 2 | 2020 | 26 | 0.320 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 815 | 0.310 |
Why?
| | Retrospective Studies | 20 | 2022 | 15657 | 0.300 |
Why?
| | Inpatients | 1 | 2013 | 500 | 0.300 |
Why?
| | Vascular Patency | 4 | 2020 | 106 | 0.270 |
Why?
| | Coronary Stenosis | 2 | 2017 | 38 | 0.270 |
Why?
| | Acute Coronary Syndrome | 2 | 2022 | 279 | 0.270 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1066 | 0.260 |
Why?
| | Follow-Up Studies | 7 | 2021 | 5131 | 0.260 |
Why?
| | Arterial Occlusive Diseases | 2 | 2018 | 83 | 0.250 |
Why?
| | Logistic Models | 5 | 2017 | 2074 | 0.240 |
Why?
| | Heart Failure | 1 | 2018 | 2236 | 0.230 |
Why?
| | Survival Rate | 6 | 2021 | 1972 | 0.230 |
Why?
| | Limb Salvage | 3 | 2019 | 57 | 0.230 |
Why?
| | Prognosis | 6 | 2021 | 4030 | 0.220 |
Why?
| | Comorbidity | 3 | 2019 | 1622 | 0.220 |
Why?
| | Propensity Score | 3 | 2021 | 294 | 0.210 |
Why?
| | Incidence | 7 | 2019 | 2804 | 0.200 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 2031 | 0.190 |
Why?
| | Iliac Artery | 2 | 2020 | 55 | 0.180 |
Why?
| | Paclitaxel | 1 | 2022 | 230 | 0.180 |
Why?
| | Practice Guidelines as Topic | 3 | 2019 | 1587 | 0.180 |
Why?
| | Cardiovascular Diseases | 3 | 2020 | 2111 | 0.180 |
Why?
| | Punctures | 2 | 2018 | 40 | 0.180 |
Why?
| | Patient Readmission | 5 | 2019 | 697 | 0.180 |
Why?
| | Troponin | 1 | 2021 | 50 | 0.170 |
Why?
| | Heart Failure, Systolic | 1 | 2021 | 25 | 0.170 |
Why?
| | Hospitals, Community | 1 | 2020 | 52 | 0.170 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1509 | 0.160 |
Why?
| | Assisted Circulation | 1 | 2019 | 26 | 0.160 |
Why?
| | Lithotripsy | 1 | 2020 | 48 | 0.160 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 530 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 46 | 0.160 |
Why?
| | Access to Information | 1 | 2019 | 49 | 0.160 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 179 | 0.150 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 86 | 0.150 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.150 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2019 | 18 | 0.150 |
Why?
| | Prostate | 1 | 2020 | 175 | 0.150 |
Why?
| | Endocrinologists | 1 | 2018 | 13 | 0.150 |
Why?
| | Atrioventricular Block | 1 | 2019 | 37 | 0.150 |
Why?
| | Chronic Disease | 2 | 2023 | 1793 | 0.150 |
Why?
| | Thrombosis | 1 | 2022 | 371 | 0.150 |
Why?
| | Office Visits | 1 | 2018 | 93 | 0.140 |
Why?
| | Laser Therapy | 1 | 2019 | 130 | 0.140 |
Why?
| | Heart Block | 1 | 2018 | 42 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2018 | 66 | 0.140 |
Why?
| | Quality Improvement | 2 | 2019 | 1178 | 0.140 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2018 | 261 | 0.140 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5472 | 0.140 |
Why?
| | Stroke Volume | 1 | 2021 | 612 | 0.140 |
Why?
| | Carotid Artery, Internal | 1 | 2017 | 42 | 0.140 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 534 | 0.140 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2017 | 37 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 350 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 530 | 0.130 |
Why?
| | Cardiology | 1 | 2019 | 274 | 0.130 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 322 | 0.130 |
Why?
| | American Heart Association | 1 | 2018 | 306 | 0.130 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 68 | 0.130 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 96 | 0.130 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 114 | 0.130 |
Why?
| | Patient Admission | 1 | 2018 | 197 | 0.130 |
Why?
| | Hospitalization | 4 | 2021 | 2199 | 0.120 |
Why?
| | Angiography | 1 | 2017 | 207 | 0.120 |
Why?
| | Decision Making | 2 | 2021 | 900 | 0.120 |
Why?
| | Angina, Unstable | 1 | 2016 | 76 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2016 | 157 | 0.120 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 494 | 0.120 |
Why?
| | Proportional Hazards Models | 2 | 2016 | 1266 | 0.110 |
Why?
| | Outpatients | 1 | 2018 | 396 | 0.110 |
Why?
| | Cause of Death | 2 | 2019 | 434 | 0.110 |
Why?
| | Body Weight | 1 | 2019 | 985 | 0.110 |
Why?
| | Electronic Health Records | 2 | 2019 | 1069 | 0.110 |
Why?
| | Prospective Studies | 4 | 2020 | 7604 | 0.110 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 249 | 0.110 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1050 | 0.110 |
Why?
| | Acute Disease | 1 | 2017 | 1007 | 0.110 |
Why?
| | Echocardiography | 1 | 2016 | 642 | 0.100 |
Why?
| | Pacemaker, Artificial | 2 | 2018 | 119 | 0.100 |
Why?
| | Recovery of Function | 1 | 2017 | 653 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 1043 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2828 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1786 | 0.100 |
Why?
| | Hospitals | 2 | 2019 | 691 | 0.090 |
Why?
| | Michigan | 3 | 2022 | 109 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 1171 | 0.090 |
Why?
| | Overweight | 1 | 2016 | 558 | 0.090 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2844 | 0.090 |
Why?
| | Tunica Intima | 1 | 2010 | 84 | 0.080 |
Why?
| | Hypertension | 1 | 2019 | 1295 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Carotid Arteries | 1 | 2010 | 206 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 245 | 0.080 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 95 | 0.070 |
Why?
| | Mortality | 2 | 2020 | 362 | 0.070 |
Why?
| | Body Mass Index | 1 | 2016 | 2389 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1357 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2069 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 333 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 2531 | 0.060 |
Why?
| | Defibrillators, Implantable | 1 | 2009 | 315 | 0.060 |
Why?
| | Program Evaluation | 2 | 2017 | 898 | 0.050 |
Why?
| | Prevalence | 2 | 2019 | 2734 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 889 | 0.040 |
Why?
| | Angina Pectoris | 1 | 2020 | 65 | 0.040 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 82 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 217 | 0.040 |
Why?
| | Health Facilities | 1 | 2019 | 84 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4565 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 59 | 0.040 |
Why?
| | Heart | 1 | 2022 | 655 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 152 | 0.040 |
Why?
| | California | 1 | 2019 | 431 | 0.040 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 25 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 342 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1236 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 307 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1060 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 273 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2017 | 331 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 1993 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 356 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1020 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 683 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 696 | 0.030 |
Why?
| | Coronary Disease | 1 | 2016 | 385 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.030 |
Why?
| | Critical Illness | 1 | 2019 | 811 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 382 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 556 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1291 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3284 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 324 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 759 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2009 | 226 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2009 | 512 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1477 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 13209 | 0.010 |
Why?
| | Adult | 2 | 2018 | 37929 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21513 | 0.010 |
Why?
|
|
Valle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|